Results 11 to 20 of about 2,851 (167)

An Exceedingly Rare Case of Mechanobullous Epidermolysis Bullosa Acquisita in a Prepubertal Child: A Review of the Clinical and Laboratory Considerations [PDF]

open access: yesAntibodies
Introduction: Epidermolysis bullosa acquisita (EBA) is a rare autoimmune disease causing subepithelial blistering due to autoantibodies against type VII collagen.
Aleksandra Wiktoria Bratborska   +3 more
doaj   +2 more sources

Complexities of care in a pediatric patient with epidermolysis bullosa acquisita and duchenne muscular dystrophy: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Type VII collagen autoantibodies drive epidermolysis bullosa acquisita (EBA), a rare autoimmune blistering disorder. While typically seen in adults, pediatric cases—especially those with additional comorbidities—present unique clinical ...
Khayry Al-Shami   +7 more
doaj   +2 more sources

Diagnosis of Epidermolysis Bullosa Acquisita: Multicentre Comparison of Different Assays for Serum Anti-type VII Collagen Reactivity [PDF]

open access: yesActa Dermato-Venereologica, 2021
Epidermolysis bullosa acquisita is a pemphigoid disease characterized by autoantibodies against type VII collagen. This study compared the sensitivity and specificity of 6 diagnostic assays: type VII collagen non-collagenous domains enzyme-linked ...
Maike M. Holtsche   +9 more
doaj   +2 more sources

Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study [PDF]

open access: yesActa Dermato-Venereologica
Epidermolysis bullosa acquisita (EBA) rarely develops in childhood. This study retrospectively recruited paediatric patients with EBA (age ≤ 16 years), diagnosed by clinical and histopathological features and results of immunofluorescence, immunoblotting
Yuexin Zhang   +5 more
doaj   +2 more sources

Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita [PDF]

open access: yesFrontiers in Immunology
Epidermolysis bullosa acquisita (EBA) is a muco-cutaneous autoimmune disease characterized and caused by autoantibodies targeting type VII collagen (COL7). The treatment of EBA is notoriously difficult, with a median time to remission of 9 months.
Natalie Gross   +6 more
doaj   +2 more sources

Epidermolysis Bullosa Acquisita

open access: yesIndian Journal of Dermatology, 1997
A 35 years old man presented with features of epidermolysis bullosa acquisita. Here is the case report.
Gangopadhyay Asok Kumar
doaj   +3 more sources

IgM-mediated epidermolysis bullosa acquisita [PDF]

open access: yesJAAD Case Reports
Sidney Harrison, BS   +3 more
doaj   +2 more sources

Epidermolysis bullosa acquisita: A report of four cases

open access: yesIndian Journal of Dermatology, 2022
Abhishek De   +4 more
doaj   +2 more sources

Whole-genome expression Profiling in skin reveals sYK as a Key regulator of inflammation in experimental epidermolysis Bullosa acquisita [PDF]

open access: yes, 2018
Because of the morbidity and limited therapeutic options of autoimmune diseases, there is a high, and thus far, unmet medical need for development of novel treatments.
Aga   +57 more
core   +10 more sources

Diagnostic Value and Practicability of Serration Pattern Analysis by Direct Immunofluorescence Microscopy in Pemphigoid Diseases

open access: yesActa Dermato-Venereologica, 2021
In pemphigoid diseases, direct immunofluorescence can be used to differentiate 2 patterns of antibody deposition at the dermal–epidermal junction; u- and n-serrated pattern.
Maike M. Holtsche   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy